zkLink (ZKL) fluctuates 63.3% in 24 hours: Low liquidity market amplifies price swings
Bitget Pulse2026/05/14 02:05Volatility Overview
In the past 24 hours, ZKL's price has risen from a low of $0.0006124 to a high of $0.0009998. The current quote is $0.0007558, with a price fluctuation as high as 63.3%. The 24-hour trading volume is around $105,000-$190,000, with a market cap of approximately $340,000. The trading volume/market cap ratio exceeds 30%, indicating a high turnover rate.
Brief Analysis of the Cause of the Fluctuation
- Dominated by Low Liquidity: ZKL's market cap is low (about $340,000), and trading depth is shallow, so even small amounts of capital can trigger sharp price movements. Bitget's monitoring shows 24-hour volatility reached 47%, which aligns with the latest 63.3% spike.
- No Significant External Events: There have been no official announcements, no large on-chain whale transfers, and no mainstream news-driven events in the past 24 hours. Discussions on X platform are scarce and mainly revolve around general TA, with no specific triggers for this volatility.
Market Sentiment and Outlook
Market sentiment is neutral to cautious, with limited community discussion. TA opinions focus on the support level near $0.000623. Short-term bullish view targets $0.0007, but note emphasized low liquidity risks. Mainstream platforms predict neutral price movements in 2026, with risk warnings about further liquidity depletion potentially increasing volatility.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Marmot Researchers Turn to OnlyFans for Funding—And There Are Meme Coins Too
New Non-Opioid Pain Relief Company Latigo (LTGO.US) Plans IPO to Raise Up to $288 Million, Nav1.8 Inhibitor Targets Vertex Pharmaceuticals (VRTX.US) Billion-Dollar Market
Pain therapy biotechnology company Latigo Biotherapeutics has finalized the terms for a $272 million IPO.

Euro holds ground as Eurozone growth data offsets oil-driven CAD gains
Earnings Preview | Pfizer (PFE.US) and Merck (MRK.US) Announce Results on the Same Day: As Patent Cliff Meets New Growth Engines, the Pharmaceutical Industry Faces a Valuation Test
Pfizer and Merck released their Q2 earnings report on the same day: one faces the major test of the “post-COVID era,” while the other is making a final push before the impending patent cliff for Keytruda.
